53 /100
HIGH RISK
Score updated Jul 13, 2026

SRXH — SRx Health Solutions Inc. Dilution Risk Tracker

Track SRXH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SRXH — Get alerts when the score changes →

As of July 13, 2026, SRx Health Solutions Inc. (SRXH) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. SRx Health Solutions Inc. has a market capitalization of $65.22M, 590.25M shares outstanding, 19 institutional holders tracked. Key dilution vectors include ATM program capacity of $2.51B, 5.38M outstanding warrants, approximately 136 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
50%
🔁 Convertible Conversion 60%
• Major convertible overhang: 518% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 55%
• 50-day avg $0.12 below $1 exchange minimum
💰 Capital Raise 18%
• Active ATM program with $2507M remaining capacity
🔔 Track SRXH — Get forecast alerts →

💹 Market Data

Market Cap$65.22M
Shares Outstanding590.25M
Float549.21M
Cash$23.54M
Debt$1.92M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 115.4% shares (2026Q1 vs prior)
19 institutional holders · 1.55M shares
#1 JANE STREET GROUP, LLC 595.2K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 247.5K shares
#3 TWO SIGMA SECURITIES, LLC 195.2K shares
+ 16 more holders Sign up free to view →

📉 Short Interest

Short Interest23.32M
Days to Cover1.0
% of Float4.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 30, 2026
xbrl XBRL CONVERTIBLE Sep 30, 2025
EFFECT EFFECT May 07, 2026
8-K 8K EVENT Mar 18, 2026
424B3 ATM Mar 06, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for SRXH Shareholders

SRx Health Solutions Inc. (SRXH) has a DilutionScore of 53/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

SRXH has an active ATM (at-the-market) program with $2.51B remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. DilutionWatch tracks 5.4M outstanding warrants for SRXH. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for SRXH in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for SRXH alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work → Warrants Explained →
Track SRXH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SRXH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SRXH
📊 SRXH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SRXH Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SRXH Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.